232 related articles for article (PubMed ID: 29123257)
1. Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
Kashiwagi E; Inoue S; Mizushima T; Chen J; Ide H; Kawahara T; Reis LO; Baras AS; Netto GJ; Miyamoto H
Br J Cancer; 2018 Jan; 118(2):213-223. PubMed ID: 29123257
[TBL] [Abstract][Full Text] [Related]
2. ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
Kawahara T; Inoue S; Ide H; Kashiwagi E; Ohtake S; Mizushima T; Li P; Li Y; Zheng Y; Uemura H; Netto GJ; Ishiguro H; Miyamoto H
Oncotarget; 2016 Aug; 7(33):53599-53610. PubMed ID: 27447553
[TBL] [Abstract][Full Text] [Related]
3. Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.
Ide H; Inoue S; Mizushima T; Kashiwagi E; Zheng Y; Miyamoto H
Mol Carcinog; 2019 Dec; 58(12):2297-2305. PubMed ID: 31535408
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-β signaling induces cisplatin resistance in bladder cancer.
Goto T; Kashiwagi E; Jiang G; Nagata Y; Teramoto Y; Baras AS; Yamashita S; Ito A; Arai Y; Miyamoto H
Am J Cancer Res; 2020; 10(8):2523-2534. PubMed ID: 32905529
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
Kawahara T; Kashiwagi E; Li Y; Zheng Y; Miyamoto Y; Netto GJ; Ishiguro H; Miyamoto H
Mol Carcinog; 2016 Feb; 55(2):161-9. PubMed ID: 25594762
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
9. Prostanoid receptors EP2, EP4, and FP are regulated by estradiol in bovine oviductal smooth muscle.
Huang N; Liu B; Dong Z; Mao W; Zhang N; Li C; Cao J
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):170-5. PubMed ID: 26319698
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer.
Kashiwagi E; Ide H; Inoue S; Kawahara T; Zheng Y; Reis LO; Baras AS; Miyamoto H
Oncotarget; 2016 Aug; 7(31):49169-49179. PubMed ID: 27322140
[TBL] [Abstract][Full Text] [Related]
11. Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear.
Hori R; Nakagawa T; Yamamoto N; Hamaguchi K; Ito J
BMC Neurosci; 2010 Mar; 11():35. PubMed ID: 20219142
[TBL] [Abstract][Full Text] [Related]
12. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone promoted gastric cancer growth through prostaglandin E receptor (EP2 and EP4) in vivo and in vitro.
Shin VY; Jin HC; Ng EK; Cho CH; Leung WK; Sung JJ; Chu KM
Cancer Sci; 2011 May; 102(5):926-33. PubMed ID: 21261791
[TBL] [Abstract][Full Text] [Related]
13. Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.
Kim SH; Ho JN; Jin H; Lee SC; Lee SE; Hong SK; Lee JW; Lee ES; Byun SS
Investig Clin Urol; 2016 Jan; 57(1):63-72. PubMed ID: 26966728
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-θ activation.
Takahashi T; Uehara H; Ogawa H; Umemoto H; Bando Y; Izumi K
Oncotarget; 2015 Mar; 6(7):4829-44. PubMed ID: 25638159
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
[TBL] [Abstract][Full Text] [Related]
16. Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancer.
Huang HF; Shu P; Murphy TF; Aisner S; Fitzhugh VA; Jordan ML
Mol Cancer Res; 2013 Apr; 11(4):427-39. PubMed ID: 23364535
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity.
Ishiguro H; Kawahara T; Zheng Y; Kashiwagi E; Li Y; Miyamoto H
Cancer Chemother Pharmacol; 2014 Aug; 74(2):249-55. PubMed ID: 24880571
[TBL] [Abstract][Full Text] [Related]
18. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
Hayden A; Douglas J; Sommerlad M; Andrews L; Gould K; Hussain S; Thomas GJ; Packham G; Crabb SJ
Urol Oncol; 2014 Aug; 32(6):806-14. PubMed ID: 24837013
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
[TBL] [Abstract][Full Text] [Related]
20. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]